The National Health Service (General Medical Services Contracts) (Scotland) Regulations 2018

JurisdictionScotland
CitationSSI 2018/66
(1) These Regulations may be cited as the National Health Service (General Medical Services Contracts) (Scotland) Regulations 2018.(2) (3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • to which the National Health Service (General Medical Services Contracts) (Scotland) Regulations 2004
  • which is entered into between a contractor and the Health Board on or after 1st April 2018.
  • (1) In these Regulations—
    • “the Act” means the National Health Service (Scotland) Act 1978;
    • ...
    • the 2004 Act” means the Primary Medical Services (Scotland) Act 2004
    • ;
    • “the 2004 Regulations” means the National Health Service (General Medical Services Contracts) (Scotland) Regulations 2004;
    • “the 2010 Order” means the Postgraduate Medical Education and Training Order of Council 2010
    • ;
    • “additional services” means one or more of—
      • (a) cervical screening services;
      • (b) contraceptive services;
      • (c) ...
      • (d) ...
      • (e) child health surveillance services; and
      • (f) maternity medical services;
    • “adjudicator” means the Scottish Ministers or a panel of 3 persons appointed by the Scottish Ministers (as the case may be) under paragraph 91 of schedule 6;
    • “advanced electronic signature” means an advanced electronic signature within the meaning given in Article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council of 23rd July 2014 on electronic identification and trust services for electronic transactions in the internal market and repealing Directive 1993/93/EC;
    • “appliance” means an appliance which is included in a list for the time being approved by the Scottish Ministers for the purposes of section 27(1) of the Act
    • ;
    • “area medical committee” means the committee of that name recognised under section 9 of the Act
    • (local consultative committees) in the area of the Health Board;
    • “area pharmaceutical committee” means the committee of that name recognised under section 9 of the Act (local consultative committees) in the area of the Health Board;
    • “assessment panel” means a committee or subcommittee of a Health Board (“the first Health Board”) (other than the Health Board (“the second Health Board”) which is a party or prospective party to the contract in question) appointed by the first Health Board at the request of the second Health Board to exercise functions under paragraph 2 or 3 of schedule 2 or paragraph 28, 32, or 37 of schedule 6 and which must consist of—
      • (a) the Chief Executive of the first Health Board or an Executive Director of that Health Board nominated by that Chief Executive;
      • (b) a person representative of patients in an area other than that of the second Health Board; and
      • (c) a person representative of the area medical committee which does not represent practitioners in the area of the second Health Board;
    • “care home service” has the same meaning as in paragraph 2 of schedule 12 of the Public Services Reform (Scotland) Act 2010
    • ;
    • “CCT” means a Certificate of Completion of Training awarded under section 34L(1) of the Medical Act 1983
    • , including any such certificate awarded in pursuance of the competent authority functions of the General Medical Council specified in section 49B and schedule 4A of that Act;
    • “cervical screening services” means the services described in paragraph 2(2) of schedule 1;
    • “charity trustee” means one of the persons having the general control and management of the administration of...

    To continue reading

    Request your trial

    VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT